OpenBilldrug price receipt

NADAC week of 2026-10-14

CARVEDILOL 6.25 MG TABLET

For 30 tablets

Pharmacies pay

$0.54 filed

30 × $0.01794 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23, 2026-10-07 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$1.95 filed

30 × $0.06495 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

3.6× estimated

Medicare paid 3.6× what pharmacies pay.

Part D averages every strength and form sold under “Carvedilol” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23, 2026-10-07 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$5.62 estimated

$0.54 + $0.08 (15%) + $5.00 fee per fill = $5.62

This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23, 2026-10-07 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

CARVEDILOL 6.25 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as carvedilol.

FDA gives its dosage form as tablet, film coated and its route as oral.

FDA lists 10 labelers (the companies named on the label) for its NDCs, among them Teva Pharmaceuticals USA, Inc., Major Pharmaceuticals and Aurobindo Pharma Limited.

FDA lists it under 2 Established Pharmacologic Classes: alpha-Adrenergic Blocker and beta-Adrenergic Blocker.

The NADAC file of 2026-10-14 prices it under 22 NDCs (National Drug Codes); the FDA directory lists 20 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $0.54 for 30 tablets (30 × $0.01794 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; those prices took effect between 2026-09-23 and 2026-10-07. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The 10 labelers

LabelerNDCsPharmacies pay per unit
Advagen Pharma Ltd6$0.01794 per EA filed
Aurobindo Pharma Limited2$0.01794 per EA filed
BluePoint Laboratories2$0.01794 per EA filed
Glenmark Pharmaceuticals Inc., USA2$0.01794 per EA filed
Teva Pharmaceuticals USA, Inc.2$0.01794 per EA filed
Zydus Pharmaceuticals USA Inc.2$0.01794 per EA filed
American Health Packaging1$0.01794 per EA filed
Major Pharmaceuticals1$0.01794 per EA filed
Quallent Pharmaceuticals Health LLC1$0.01794 per EA filed
UNICHEM PHARMACEUTICALS (USA), INC.1$0.01794 per EA filed
Not listed as a package in the FDA directory2$0.01794 per EA filed

When these prices took effect

All 22 NDCs, with labeler and price
  • 00093-0135-01 · Teva Pharmaceuticals USA, Inc. · $0.01794 per EA · eff. 2026-09-23 filed
  • 00093-0135-05 · Teva Pharmaceuticals USA, Inc. · $0.01794 per EA · eff. 2026-09-23 filed
  • 00904-7306-61 · Major Pharmaceuticals · $0.01794 per EA · eff. 2026-09-23 filed
  • 65862-0143-01 · Aurobindo Pharma Limited · $0.01794 per EA · eff. 2026-09-23 filed
  • 65862-0143-05 · Aurobindo Pharma Limited · $0.01794 per EA · eff. 2026-09-23 filed
  • 68001-0154-00 · BluePoint Laboratories · $0.01794 per EA · eff. 2026-09-23 filed
  • 68001-0154-03 · BluePoint Laboratories · $0.01794 per EA · eff. 2026-09-23 filed
  • 68084-0854-01 · American Health Packaging · $0.01794 per EA · eff. 2026-09-23 filed
  • 68084-0854-11 · not listed as a package in the FDA directory · $0.01794 per EA · eff. 2026-09-23 filed
  • 68382-0093-01 · Zydus Pharmaceuticals USA Inc. · $0.01794 per EA · eff. 2026-09-23 filed
  • 68382-0093-05 · Zydus Pharmaceuticals USA Inc. · $0.01794 per EA · eff. 2026-09-23 filed
  • 68462-0163-01 · Glenmark Pharmaceuticals Inc., USA · $0.01794 per EA · eff. 2026-09-23 filed
  • 68462-0163-05 · Glenmark Pharmaceuticals Inc., USA · $0.01794 per EA · eff. 2026-09-23 filed
  • 68645-0350-59 · not listed as a package in the FDA directory · $0.01794 per EA · eff. 2026-09-23 filed
  • 72888-0035-00 · Advagen Pharma Ltd · $0.01794 per EA · eff. 2026-09-23 filed
  • 72888-0035-01 · Advagen Pharma Ltd · $0.01794 per EA · eff. 2026-09-23 filed
  • 72888-0035-05 · Advagen Pharma Ltd · $0.01794 per EA · eff. 2026-09-23 filed
  • 72888-0500-01 · Advagen Pharma Limited · $0.01794 per EA · eff. 2026-09-23 filed
  • 72888-0500-02 · Advagen Pharma Limited · $0.01794 per EA · eff. 2026-09-23 filed
  • 72888-0500-03 · Advagen Pharma Limited · $0.01794 per EA · eff. 2026-10-07 filed
  • 76385-0111-50 · UNICHEM PHARMACEUTICALS (USA), INC. · $0.01794 per EA · eff. 2026-09-23 filed
  • 82009-0126-05 · Quallent Pharmaceuticals Health LLC · $0.01794 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

3 other products in the NADAC file share the FDA nonproprietary name carvedilol with CARVEDILOL 6.25 MG TABLET.

ProductPharmacies pay per unitMedicare per unit
CARVEDILOL 3.125 MG TABLET
generic · tablet, film coated
$0.01664 per EA filed
eff. 2026-09-23 to 2026-10-07
$0.06495 per EA filed
Part D 2024 average
CARVEDILOL 6.25 MG TABLET this page
generic · tablet, film coated
$0.01794 per EA filed
eff. 2026-09-23 to 2026-10-07
$0.06495 per EA filed
Part D 2024 average
CARVEDILOL 12.5 MG TABLET
generic · tablet, film coated
$0.0216 per EA filed
eff. 2026-09-23
$0.06495 per EA filed
Part D 2024 average
CARVEDILOL 25 MG TABLET
generic · tablet, film coated
$0.03235 per EA filed
eff. 2026-09-23 to 2026-10-07
$0.06495 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23, 2026-10-07 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 22 NDCs’ NADAC prices is $0.01794 per EA filed.

Of the 24 other products in FDA’s alpha-Adrenergic Blocker class priced per EA, 23 have a higher middle NADAC price and 1 a lower one. The one in the middle is TERAZOSIN 2 MG CAPSULE, at $0.10551 per EA filed (eff. 2026-09-23).

Of the 76 other products in FDA’s beta-Adrenergic Blocker class priced per EA, 74 have a higher middle NADAC price and 2 a lower one. The one in the middle is NADOLOL 40 MG TABLET, at $0.26544 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $1.95 for 30 tablets, at an average of $0.06495 per EA in 2024 (2024-01-01 to 2024-12-31) for “Carvedilol”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 15,794,645 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for CARVEDILOL 6.25 MG TABLET labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Carvedilol / Carvedilol: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.